Arrowhead Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Pasadena, CA
ARWR chart
What traders are saying about $ARWR
Latest postsArrowhead Pharmaceuticals, Inc. news
- Arrowhead Pharmaceuticals Says MHRA Grants Marketing Authorisation For REDEMPLO For FCS In Adults
TradingView ·
- Adults Living with Familial Chylomicronaemia Syndrome (FCS) in England and Wales Have REDEMPLO® (Plozasiran) as a New Treatment Option to Reduce Triglycerides
Yahoo Finance ·
- Arrowhead Pharmaceuticals (ARWR), What Is Behind Its Latest Update?
Simply Wall Street ·
- Sat Out Arrowhead Pharmaceuticals' Rally? Here Is What Holders Saw
Simply Wall Street ·
- Arrowhead Pharmaceuticals (Nasdaq:ARWR) - Stock Analysis
Simply Wall Street ·
- Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own
Yahoo Finance ·
- 3 Biotech Stocks Trading At Least 43% Below Fair Value
Simply Wall Street ·
- Arrowhead Pharmaceuticals, Inc. Estimates – NASDAQ:ARWR
TradingView ·
- Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Forecasts
Yahoo Finance ·
- Arrowhead Pharmaceuticals Announces Interim Data from Tau Clinical Trial, FDA Consultation for FTD-MAPT and PSP Studies
AFTD - The Association for Frontotemporal Degeneration ·
- How Investors Are Reacting To Arrowhead Pharmaceuticals (ARWR) Brain Drug Trial Progress
Simply Wall Street ·
Arrowhead Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $829.4M | $3.6M | $240.7M | $243.2M |
| Net income | -$1.6M | -$599.5M | -$205.3M | -$176.1M |
| Diluted EPS | $-0.01 | $-5.00 | $-1.92 | $-1.67 |
| Total assets (year end) | $1.60B | $1.01B | $626.3M | $891.5M |
| Cash and equivalents (year end) | – | – | $58.2M | $202.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arrowhead Pharmaceuticals, Inc.
- Ticker
- ARWR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Pasadena, CA
- Incorporated in
- DE
- Fiscal year end
- September 30
- SEC CIK
- 879407
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Frequently asked questions
What exchange is Arrowhead Pharmaceuticals, Inc. listed on?
Arrowhead Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ARWR.
What industry is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arrowhead Pharmaceuticals, Inc. headquartered?
Arrowhead Pharmaceuticals, Inc.'s business address on file with the SEC is in Pasadena, CA.
When does Arrowhead Pharmaceuticals, Inc.'s fiscal year end?
Arrowhead Pharmaceuticals, Inc.'s fiscal year ends on September 30.
How much revenue did Arrowhead Pharmaceuticals, Inc. report?
Arrowhead Pharmaceuticals, Inc. reported $829.4M in revenue for calendar year 2025, according to its SEC filings.